Ledger.Open graph →
SEC Form D · Amendment · filed June 29, 2015

Neurovance, Inc

Offering
$26.5M
Sold
$26.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Michael A. Groneberg · MINNEAPOLIS, MNDirectorBrett D. Forman · Palm Beach, FLDirectorCharles J. Neverdowski · Houston, TXExecCampbell P. Murray · Cambridge, MADirectorFred Altimont · Washington, Washington, D.C.ExecTroy L. Beckett · Houston, TXExec · DirectorFranklin P. Bymaster · Brownsburg, INExecPaul A. Weiss · Madison, WIDirectorDavid Smith · Austin, TXDirectorSusan Oh · Denver, CODirectorBrigitte T. Robertson · Cambridge, MAExecTimothy J. Barberich · Concord, MADirectorWilliam T. Pappafotopoulos · Cambridge, MAExecPaul Stevenson · Smiths, BermudaDirectorAlbert L. Sokol · Boston, MAExecW. D. Spies · Houston, TXExecGeoff Huber · MINNEAPOLIS, MNExec · DirectorJeri P. Wechsler · Houston, TXExecAnthony A. Mckinney · Cambridge, MAExec · DirectorDaniel A. Omstead · Boston, MADirectorColin Carr · Lone Tree, COExecGeorge Batejan · Denver, CODirectorAnna M. Lantz · Houston, TXDirectorBrigitte A. Smith · Melbourne VIC, Channel IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗